Lucy Frith
Publications by Year
Research Areas
Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery, Respiratory and Cough-Related Research, Chronic Obstructive Pulmonary Disease (COPD) Research, Maternal and Perinatal Health Interventions
Most-Cited Works
- → Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease(1998)509 cited
- → Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice(2016)194 cited
- → Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial(2017)115 cited
- → Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis(2022)103 cited
- → Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone(2013)86 cited
- → Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids(2012)51 cited
- → Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma(2011)45 cited
- → Rate of Response of Individual Asthma Control Measures Varies and May Overestimate Asthma Control: An Analysis of the Goal Study(2007)36 cited
- → Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trial(2012)30 cited
- → Salmeterol/Fluticasone Propionate via Diskus™ Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids(2008)20 cited